OPKO R&D Facility
![](/46/pdcnewsitem/04/74/79/Picture5.jpg)
EirGen have commenced construction of a state of the art R&D facility in the Business and technology Park, Cork road, Waterford (Opposite the Whitfield clinic). The facility will be construction complete in Q2 2018 with a phased start up leading to full readiness in early 2019.
The facility provides R&D, clinical and commercial capability to develop Injectable products (Vial, Syringe and cartridge) through a multi-purpose aseptic fill line; freeze dried or liquid and high potency if required. It will also enhance EirGen’s current capability in the development of high potency Oral Solid Dose products, with a new R&D Oral Solid Dose facility. Extensive Labs for research and development are also being built.
This facility will give EirGen a unique flexibility in the development of products for its parent company, OPKO. It offers many varied R&D opportunities across multiple disciplines further enhancing EirGen’s position as the employer of choice in R&D.
![EIRGEN PHARMA LIMITED](https://www.cphi-online.com/c247517th_S-comp247517.jpg)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance